Executive record

Andrs Conesa Ph.D

Public governance roles and source-backed Claims for this individual.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:andrs-conesa-ph-dVersion: public-0As of: 2026-09-30

Not yet claimed11 published Claims3 sources

Key Claims

Biography

Former CEO of NodThera and business development leader at Sanofi and Johnson & Johnson with a background as a discovery scientist.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Claims

Executive career

  1. 2026 to end not publishedExecutive title: Executive Vice President, Head of Corporate Development · Organization not publishedBIIB 10-K executive officers

Claims

Conflicts and accountability

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. BIIB 10-K executive officers

    sec filing · Source published: Feb 6, 2026 · Retrieved: Apr 29, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: Apr 29, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: Apr 29, 2026
    • Executive company: Executive at Biogen Inc. · Claim reviewed: May 3, 2026
    • Executive title: Executive title: Executive Vice President, Head of Corporate Development · Claim reviewed: May 3, 2026
    • Other Company Role: Adam Keeney, Ph.D. is also linked to NodThera as Chief Executive Officer. · Claim reviewed: Apr 29, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: Apr 29, 2026

  2. Sempra director board source

    sec filing · Source published: Mar 28, 2025 · Retrieved: May 3, 2026

    Supports 2 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Sempra · Claim reviewed: May 3, 2026

  3. BIIB executive roster source

    sec filing · Source published: Date unavailable · Retrieved: May 3, 2026

    Supports 5 claims
    • AI expertise: AI expertise reported in filings · Claim reviewed: May 3, 2026
    • AI governance relevance: AI governance relevance reported from role and filings · Claim reviewed: May 3, 2026
    • Executive company: Executive at Biogen Inc. · Claim reviewed: May 3, 2026
    • Executive function: Other Executive (EVP) · Claim reviewed: May 3, 2026
    • Executive title: Executive title: Executive Vice President, Head of Corporate Development · Claim reviewed: May 3, 2026